TSC22D3 and plasma cell myeloma: Studies have shown that GCs rapidly upregulated the expression of GILZ in T lymphocytes, multiple myeloma cells, mesenchymal stem cells, and human airway epithelial cells, among others [11], [16], [30], [31].